ArticleAnnals of medicine and surgery (2012)2026
Brensocatib (Brinsupri) first FDA-approved targeted therapy for non-cystic fibrosis bronchiectasis.
Zuha Babar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it